<![CDATA[Pharma — August 2023]]>Medicinalkæmpen Johnson & Johnson dykkede 4 pct., efter selskabet har fået afvist en konkurs i sit datterselskab LTL Management af en føderal domstol i USA.
Dommen faldt fredag og omhandler en konkursbegæring i datterselskabet, der er oprettet med henblik på at sætte en stopper for en lang række sager om kræft udløst af selskabets babypulver med talkum.

]]>https://dev.proinvestor.com/forum/topic/400877/pharma-august-2023RSS for NodeSun, 07 Jun 2026 08:12:43 GMTTue, 01 Aug 2023 04:49:40 GMT60<![CDATA[Reply to Pharma — August 2023 on Fri, 25 Aug 2023 02:52:04 GMT]]>ALKs kursmål sænkes næsten 30 pct. hos ABG https://www.proinvestor.com/investornyt/1040211/alks-kursmal-saenkes-naesten-30-pct-hos-abg

]]>https://dev.proinvestor.com/forum/post/8037906https://dev.proinvestor.com/forum/post/8037906Fri, 25 Aug 2023 02:52:04 GMT<![CDATA[Reply to Pharma — August 2023 on Thu, 24 Aug 2023 06:13:55 GMT]]>ALK topchef om tabletsalg i Europa: Har indikationer på at de næste kvartaler bliver gode https://www.proinvestor.com/investornyt/1039573/alk-topchef-om-tabletsalg-i-europa-har-indikationer-pa-at-de-naeste-kvartaler-bliver-gode

]]>https://dev.proinvestor.com/forum/post/8037908https://dev.proinvestor.com/forum/post/8037908Thu, 24 Aug 2023 06:13:55 GMT<![CDATA[Reply to Pharma — August 2023 on Thu, 24 Aug 2023 04:34:25 GMT]]>ALK- et kvartalsregnskaber uden allergiske reaktioner https://www.proinvestor.com/boards/114901

]]>https://dev.proinvestor.com/forum/post/8037903https://dev.proinvestor.com/forum/post/8037903Thu, 24 Aug 2023 04:34:25 GMT<![CDATA[Reply to Pharma — August 2023 on Thu, 24 Aug 2023 04:01:09 GMT]]>ALK-Abelló - halvårsrapport
https://www.proinvestor.com/boards/114899

]]>https://dev.proinvestor.com/forum/post/8037907https://dev.proinvestor.com/forum/post/8037907Thu, 24 Aug 2023 04:01:09 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 22 Aug 2023 07:28:06 GMT]]>Børshuse ser fortsat Lundbecks prognose som konservativ trods opjustering https://www.proinvestor.com/investornyt/1038238/borshuse-ser-fortsat-lundbecks-prognose-som-konservativ-trods-opjustering

]]>https://dev.proinvestor.com/forum/post/8037905https://dev.proinvestor.com/forum/post/8037905Tue, 22 Aug 2023 07:28:06 GMT<![CDATA[Reply to Pharma — August 2023 on Sat, 19 Aug 2023 02:47:27 GMT]]>Lundbeck må tage afsked med direktør for HR- og kommunikation https://www.proinvestor.com/investornyt/1036831/lundbeck-ma-tage-afsked-med-direktor-for-hr-og-kommunikation

]]>https://dev.proinvestor.com/forum/post/8037901https://dev.proinvestor.com/forum/post/8037901Sat, 19 Aug 2023 02:47:27 GMT<![CDATA[Reply to Pharma — August 2023 on Sat, 19 Aug 2023 02:43:25 GMT]]>Novartis planlægger børsnotering af Sandoz i oktober https://www.proinvestor.com/investornyt/1036942/novartis-planlaegger-borsnotering-af-sandoz-i-oktober

]]>https://dev.proinvestor.com/forum/post/8037904https://dev.proinvestor.com/forum/post/8037904Sat, 19 Aug 2023 02:43:25 GMT<![CDATA[Reply to Pharma — August 2023 on Fri, 18 Aug 2023 04:49:28 GMT]]>Lundbeck (+2,7%, 42,50) får efter onsdagens regnskab hævet anbefalingen til "køb" fra "hold" af finanshuset Morningstar.
Det viser data fra Bloomberg News. Kursmålet fastholdes på 42,50 kr. Marketwire

]]>https://dev.proinvestor.com/forum/post/8037902https://dev.proinvestor.com/forum/post/8037902Fri, 18 Aug 2023 04:49:28 GMT<![CDATA[Reply to Pharma — August 2023 on Wed, 16 Aug 2023 10:46:16 GMT]]>Danske Bank skærer kursmålet for ALK: Bekymringerne over tabletsalget i Europa fortsætter https://www.proinvestor.com/investornyt/1035263/danske-bank-skaerer-kursmalet-for-alk-bekymringerne-over-tabletsalget-i-europa-fortsaetter

]]>https://dev.proinvestor.com/forum/post/8037899https://dev.proinvestor.com/forum/post/8037899Wed, 16 Aug 2023 10:46:16 GMT<![CDATA[Reply to Pharma — August 2023 on Wed, 16 Aug 2023 09:35:02 GMT]]>Fortsat vækst og lave omkostninger sikrer opjustering hos Lundbeck https://www.proinvestor.com/investornyt/1035293/fortsat-vaekst-og-lave-omkostninger-sikrer-opjustering-hos-lundbeck

]]>https://dev.proinvestor.com/forum/post/8037898https://dev.proinvestor.com/forum/post/8037898Wed, 16 Aug 2023 09:35:02 GMT<![CDATA[Reply to Pharma — August 2023 on Wed, 16 Aug 2023 04:15:44 GMT]]>Lundbeck Q2: Slår konsensus over hele linjen https://www.proinvestor.com/boards/114728

]]>https://dev.proinvestor.com/forum/post/8037895https://dev.proinvestor.com/forum/post/8037895Wed, 16 Aug 2023 04:15:44 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 15 Aug 2023 03:02:15 GMT]]>Is Amgen Stock Fully Valued After A 17% Rise In A Month? https://www.proinvestor.com/investornyt/1034482/is-amgen-stock-fully-valued-after-a-17-rise-in-a-month

]]>https://dev.proinvestor.com/forum/post/8037900https://dev.proinvestor.com/forum/post/8037900Tue, 15 Aug 2023 03:02:15 GMT<![CDATA[Reply to Pharma — August 2023 on Mon, 14 Aug 2023 03:26:06 GMT]]>Up 45% This Year What's Driving The Growth For Eli Lilly Stock? https://www.proinvestor.com/investornyt/1033881/up-45-this-year-whats-driving-the-growth-for-eli-lilly-stock

]]>https://dev.proinvestor.com/forum/post/8037897https://dev.proinvestor.com/forum/post/8037897Mon, 14 Aug 2023 03:26:06 GMT<![CDATA[Reply to Pharma — August 2023 on Fri, 11 Aug 2023 03:48:34 GMT]]>Dagens aktie er Danaher Corporation

Danaher Corporation designer, fremstiller og markedsfører professionelle, medicinske, industrielle og kommercielle produkter og tjenester over hele verden.
Samling af 20 driftsselskaber.
Virksomheden opererer gennem tre segmenter: Life Sciences, Diagnostics og Environmental & Applied Solutions.
https://www.proinvestor.com/boards/114611

]]>https://dev.proinvestor.com/forum/post/8037896https://dev.proinvestor.com/forum/post/8037896Fri, 11 Aug 2023 03:48:34 GMT<![CDATA[Reply to Pharma — August 2023 on Thu, 10 Aug 2023 04:07:16 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037894https://dev.proinvestor.com/forum/post/8037894Thu, 10 Aug 2023 04:07:16 GMT<![CDATA[Reply to Pharma — August 2023 on Wed, 09 Aug 2023 13:42:38 GMT]]>Gilead Sciences a Top 25 Dividend Giant With 3.75% Yield (GILD) https://www.proinvestor.com/investornyt/1031382/gilead-sciences-a-top-25-dividend-giant-with-375-yield-gild

]]>https://dev.proinvestor.com/forum/post/8037888https://dev.proinvestor.com/forum/post/8037888Wed, 09 Aug 2023 13:42:38 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 08 Aug 2023 08:34:52 GMT]]>Is AbbVie Still a Good Dividend Stock to Buy? https://www.proinvestor.com/investornyt/1030213/is-abbvie-still-a-good-dividend-stock-to-buy

]]>https://dev.proinvestor.com/forum/post/8037886https://dev.proinvestor.com/forum/post/8037886Tue, 08 Aug 2023 08:34:52 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 08 Aug 2023 04:34:29 GMT]]>8.8.2023 07.29 • MarketWire •
Kursmålet for Lundbeck hæves til 46 kr. fra 44 kr. af Nordea, der fastholder anbefalingen "køb".

Det viser data fra Bloomberg.

Lundbeck-aktien sluttede mandag i 35 kr. efter en stigning på 0,8 pct. Aktien er siden nytår steget godt 34 pct.

.\˙ MarketWire

]]>https://dev.proinvestor.com/forum/post/8037891https://dev.proinvestor.com/forum/post/8037891Tue, 08 Aug 2023 04:34:29 GMT<![CDATA[Reply to Pharma — August 2023 on Thu, 03 Aug 2023 03:43:22 GMT]]>Godmorgen 🙂 ja dejligt med Teva tog lige toppen af min position 🙂

]]>https://dev.proinvestor.com/forum/post/8037887https://dev.proinvestor.com/forum/post/8037887Thu, 03 Aug 2023 03:43:22 GMT<![CDATA[Reply to Pharma — August 2023 on Wed, 02 Aug 2023 11:56:00 GMT]]>På en sådan dag er det godt med TEVA, 10% op på Q2. Hvem skulle tro at TEVA makes my day.

]]>https://dev.proinvestor.com/forum/post/8037889https://dev.proinvestor.com/forum/post/8037889Wed, 02 Aug 2023 11:56:00 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 01 Aug 2023 10:35:58 GMT]]>Amerikanske Merck opjusterer efter stærkt kvartal
https://www.proinvestor.com/investornyt/1025072/amerikanske-merck-opjusterer-efter-staerkt-kvartal

]]>https://dev.proinvestor.com/forum/post/8037892https://dev.proinvestor.com/forum/post/8037892Tue, 01 Aug 2023 10:35:58 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 01 Aug 2023 04:50:31 GMT]]>Kilde: Nordnet

]]>https://dev.proinvestor.com/forum/post/8037893https://dev.proinvestor.com/forum/post/8037893Tue, 01 Aug 2023 04:50:31 GMT<![CDATA[Reply to Pharma — August 2023 on Tue, 01 Aug 2023 04:50:03 GMT]]>Produktet blev trukket for flere år siden, da dele af indholdet blev vurderet kræftfremkaldende. Det har medført flere tusinde erstatningssager mod Johnson & Johnson, der med konkursen forsøger at begrænse et forlig til 8,9 mia. dollar.

]]>https://dev.proinvestor.com/forum/post/8037890https://dev.proinvestor.com/forum/post/8037890Tue, 01 Aug 2023 04:50:03 GMT